| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 7 |
| GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A4HLM5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 104 | 108 | PF00656 | 0.514 |
| CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.391 |
| CLV_NRD_NRD_1 | 40 | 42 | PF00675 | 0.424 |
| CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.391 |
| CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.429 |
| CLV_PCSK_PC1ET2_1 | 46 | 48 | PF00082 | 0.487 |
| CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.435 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.424 |
| DOC_MAPK_gen_1 | 2 | 12 | PF00069 | 0.354 |
| DOC_MAPK_gen_1 | 46 | 54 | PF00069 | 0.452 |
| DOC_MAPK_MEF2A_6 | 5 | 14 | PF00069 | 0.406 |
| DOC_MAPK_MEF2A_6 | 90 | 97 | PF00069 | 0.519 |
| DOC_MAPK_NFAT4_5 | 90 | 98 | PF00069 | 0.545 |
| DOC_USP7_UBL2_3 | 42 | 46 | PF12436 | 0.312 |
| LIG_14-3-3_CanoR_1 | 5 | 12 | PF00244 | 0.336 |
| LIG_Actin_WH2_2 | 106 | 122 | PF00022 | 0.411 |
| LIG_Clathr_ClatBox_1 | 26 | 30 | PF01394 | 0.412 |
| LIG_FHA_1 | 5 | 11 | PF00498 | 0.430 |
| LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.422 |
| LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.405 |
| LIG_SUMO_SIM_par_1 | 25 | 30 | PF11976 | 0.417 |
| LIG_TRAF2_1 | 15 | 18 | PF00917 | 0.424 |
| LIG_UBA3_1 | 26 | 33 | PF00899 | 0.277 |
| MOD_CK1_1 | 56 | 62 | PF00069 | 0.536 |
| MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.573 |
| MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.458 |
| MOD_GSK3_1 | 53 | 60 | PF00069 | 0.580 |
| MOD_GSK3_1 | 64 | 71 | PF00069 | 0.481 |
| MOD_PKA_2 | 4 | 10 | PF00069 | 0.432 |
| MOD_Plk_4 | 57 | 63 | PF00069 | 0.509 |
| MOD_SUMO_rev_2 | 115 | 122 | PF00179 | 0.625 |
| MOD_SUMO_rev_2 | 87 | 95 | PF00179 | 0.487 |
| TRG_DiLeu_BaEn_3 | 49 | 55 | PF01217 | 0.528 |
| TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.570 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PFY8 | Leptomonas seymouri | 81% | 100% |
| A0A0S4JTC5 | Bodo saltans | 33% | 98% |
| A0A1X0P149 | Trypanosomatidae | 53% | 100% |
| A0A3Q8IMC7 | Leishmania donovani | 89% | 100% |
| A0A3R7N3H7 | Trypanosoma rangeli | 49% | 95% |
| A4I936 | Leishmania infantum | 89% | 100% |
| C9ZIV3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
| E9B401 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| P59048 | Mus musculus | 29% | 92% |
| Q4Q423 | Leishmania major | 87% | 100% |
| Q642A0 | Rattus norvegicus | 31% | 92% |
| V5DDK9 | Trypanosoma cruzi | 50% | 100% |